Nefrolitiazisli Hastalarda 24 Saatlik İdrar ve Serum Parametreleri Arasında İlişki
Gazi Üniversitesi Tıp Fakültesi Tıbbi Biyokimya Anabilim Dalı, ANKARA
Anahtar Kelimeler: 24 Hour Urine Analysis; Nephrolithiasis; Citrate; Oxalate; Phosphate, 24 Saatlik idrar analizi; nefrolitiazis; sitrat; okzalat; fosfat
5.666 görüntülenme 3.544 indirme
Gereç ve Yöntem: 231 adet nefrolitiazisli hasta (18-65 yaşları arasında; 143 erkek, 88 kadın)retrospektif olarak incelendi.
Bulgular: İdrar ve serum kreatinin değerleri ile idrar ve serum ürik asit değerleri arasında [sırasıyla r= 0.70, (p<0.001); r= 0.55, (p<0.001)]; idrar fosforu ile idrar üre değerleri arasında (r= 0.998, p<0.001); idrar ürik asiti ile idrar kalsiyum değerleri arasında (r= 0.488, p<0.001); idrar klor değerleri ile hem idrar ürik asi hem de idrar kreatinin değerleri arasında [sırasıyla r= 0.547, (p=0.00);r= 0.59, (p<0.001)] istatiksel olarak anlamı korelasyon bulundu.
Sonuç: Bazı serum ve idrar parametreleri arasında korelasyon vardır. Nefrolitiazisli hastalarda taş oluşumu mekanizmasının daha iyi anlaşılması açısından 24 saatlik idrar analizi faydalı olabilir. Dahası bu korelasyonlar hastaya klinik yaklaşımı yönlendirebilir ve tedavi protokolünü etkileyebilir. ©2007, Fırat Üniversitesi, Tıp Fakültesi
Materials and Methods: Two hundreds thirty-one patients with nephrolithiasis (aged 18-65 years; 143 men, 88 women) were retrospectively examined in this study.
Results: Significant correlations observed between urine and serum levels of creatinine with urine and serum levels of uric acid [r= 0.70, (p<0.01) for urine; r= 0.55, (p<0.01) for serum]; urine levels of phosphorus with urine levels of urea (r= 0.998, p<0.01); urine levels of uric acid with urine levels of calcium (r= 0.488, p<0.001) and between urine levels of chlorine and uric acid (r= 0.547, p=0.00) and creatinine (r= 0.59, p<0.001).
Conclusion: In conclusion, there are some correlations between the values of urine and serum parameters. In patients with nephrolithiasis, 24-hour urine analysis may be helpful for the assessment of stone formation and development. Furthermore these correlations may conduct clinicians determine better treatment strategies. ©2007, Firat University, Medical Faculty
Introduction
Hypocitraturia is seen almost 30% of patients with nephrolithiasis. The importance of citrate in nephrolithiasis stems from the recognition that citrate is a direct inhibitor of calcium phosphate precipitation 1 and the generation of calcium oxalate crystal 2. The ability of citrate to form soluble complexes with divalent cations, such as calcium, is well known. Such complexation may cause some reduction in the urinary saturation of stone-forming calcium salts. For these reasons urinary citrate concentrations may have important rolls in renal stone formation. It has also been shown that four of every five patients with nephrolithiasis were male 3. One of the problems with citrate excretion is that it depends on age and sex; it changes with age 4 and is generally higher in women than in man 4-9.
Urine analysis is important in determining urine pH, eliminating probable infection, and the most importantly learning the type of crystals (crystals usually seen during the acute attack). Concentrations of serum electrolytes, calcium, phosphate, creatinine and uric acid have to be measured at the first biochemical investigation of patients with nephrolithiasis. In addition, 24-hour urine volume, creatinine, urea, Na+, Ca++, phosphate, uric acid, oxalate, citrate, urine pH, and serum level of Intact Para Thyroid Hormone (IPTH) may be assessed.
The purpose of this study was to find out the relation between urine and serum parameters that are measured routinely in patients with nephrolithiasis. Then more clarify formation of nephrolithiasis.
Materials and Methods
Urine volume and levels of citrate, oxalate, calcium, creatinine, urea, Na+, Ca++, phosphate, uric acid were measured. Serum electrolytes, calcium, phosphate, creatinine and uric acid levels were also determined. Urinary citrate and oxalate levels were measured spectrophotometrically with enzymatic method by means of using commercially available diagnostic kits (Roche Diagnostics, Darmstadt, Germany and Sigma, St Louis, MO; respectively). Levels of other parameters were measured using Abbott-Aeroset autoanalyzer (USA). IPTH was measured with Abbott Architect 2000 chemiluminescence immunoassay analyzer (USA).
Statistical Analysis:
The results are presented as mean±SD, students t-test was
used for statistical analysis. Pearson test was used for
correlation analysis. p values <0.05 were regarded as
statistically significant.
Results
Table 1: 24-Hour Urinary Excretions of Constituents
Table 2: Values for Serum Chemistry Tests and PTH
As a result of correlation analysis, significant correlations were found between: both urine and serum levels of creatinine with both urine and serum levels of uric acid [r= 0.70 (p<0.01), r= 0.55 (p<0.01) respectively]; urine levels of phosphorus with urine levels of urea [r=0.99 (p<0.01)]; urine levels of uric acid with urine levels of calcium [r=0.48 (p<0.01)] and between urine levels of chlorine with uric acid [r= 0.54 (p=0.00)] and creatinine [r= 0.59 (p<0.01)]. These strong relationships were shown in figure 1.
Figure 1: Relationship Between 24-Hour Urinary and Serum
Biochemical Parameters
a) Urine levels of creatinine with urine levels of uric acid
b) Serum levels of creatinine with serum levels of uric acid
c) Urine levels of uric acid with urine levels of calcium
d) Urine levels of chlorine with urine levels of uric acid
e) Urine levels of chlorine with urine levels of creatinine
Discussion
It is known that while the raised excretion of oxalate, uric acid, calcium and phosphorus in the urine increase the formation of nephrolithiasis; raised excretion of citrate, magnesium, albumin and alkali urine decrease this process. In our patients with nephrolithiasis the levels of urine citrate, calcium, uric acid, phosphorus, sodium (up limit in men), potassium, chlorine and creatininee were within normal limits but the levels of 24-hour urine volume, and urinary magnesium and oxalate excretion were higher than normal.
Several reports claim that idiopathic stone formers excrete significantly less citrate in their urine than normal subjects 5-7,9-15. Others, however, have not confirmed this difference 16-19. One of the problems with citrate excretion is that it depends on age and sex; it changes with age 4 and is generally higher in women than in man 4-9. Our results were in agreement with this data.
The levels of all serum parameters were within normal intervals but only IPTH was higher than normal in female patients. Primary hyperparathyroidism is related with stone formation in patients with nephrolithiasis. We also observed positive correlations between urine and serum levels of creatininee with urine and serum levels of uric acid; urine levels of phosphorus with urine levels of urea; urine levels of uric acid with urine levels of calcium and among the urine levels of chlorine with uric acid and creatinine.
Either Fellstrom et al. 20 in patients (n= 467) with calcium lithiasis or Dumoulin et al. 21 in patients (n= 49) with pure and mixed CaOx (calcium-oxalate) lithiasis found out a positive correlation between urine values of uric acid and oxalate. Although Duranti et al. in patients (n= 30) with calcium lithiasis found a positive correlation between urine values of calcium and phosphorus, they did not find correlation among creatininee, uric acid, urea, chlorine and magnesium excretions 22. Futhermore Conta A et al. 23 and Welshman et al. 4 in patients with CaOx lithiasis found that patients with hypocitraturia also had hypercalciuria. But Menon and Mahle described no significant correlation between calcium and citrate excretion in their controls or patients with stone 14. As a different relationship Oehlschlager et al. 24 found a combination of hypercalciuria and hyperoxaluria in patients (n= 22) after extracorporeal shock wave lithotripsy treatment. Both Tefekli A et al. and Ogava Y et al. found that levels of urine calcium were higher in patients with CaOx stones than normal patients; level of urine citrate, magnesium and creatinine were lower than normal (n= 155 and n= 222) 25,26, but Scholz et al. 27 found out that concentrations of magnesium, uric acid and phosphate were within normal limits in urine. These different results may result from the special characteristics of a particular region (diet, climate, genetics, socio-economic factors, etc.). The dietary differences may be the most important factor to explain the deviation among the various studies.
In conclusion, it is obvious that there are correlations among some urine parameters and this may be clinically useful for a more effective treatment planning.
References
1)Parks YJ, Coe LF: The financial effects of kidney stone
2)prevention. Kidney International. 1996; 50: 1706-1712
3)Bisaz S, Felix R., Newman WF, Fleisch H: Quantitative
4)determination of inhibitors of calcium phosphate precipitation in
5)whole urine. Min Electrolyte Metab. 1978; 1:74
6)Tiselius HG: Urinary Excretion of Citrate in Normal Subjects and
7)Patients with Urolithiasis. Plenum Press, New York, 1981
8)Welshman SG, Mc Geown MG: Urinary citrate excretion in
9)stone-formers and normal controls. Br J Urol. 1976; 48: 7-11
10)Hodgkinson A: Citric Acid Excretion of Citrate in Normal Adults
11)and in Patients with Renal Calculus. Clin Sci. 1962; 23: 203-212
12)Elliot JS, Riberio ME: The urinary excretion of citric, hippuric
13)and lactic acid in normal adults and in patients with calcium
14)oxalate urinary calculus disease. Invest Urol. 1972; 10: 102-106
15)Sehwille PO, Scholz D, Paulus M, Engelhardt W, Sigel A:.
16)Citrate in Daily and fasting urine. Invest Urol. 1979; 16: 457-462
17)Robertson WG, Peacock M, Nordin BEC: Activity products in
18)stone-forming urine. Clin Sci.1968; 32: 579-594
19)Welshman SG, Mc Geown MG: A quantitative investigation of
20)the effects on the growth of calcium oxalate crystals of potential
21)inhibitors. Br J Urol. 1972; 44: 677-680
22)Pylypchuk G, Ehrig U, Wilson DR: Idiopathic calcium
23)nephrolithiasis. 1. Differences in urine crystalloids, urine
24)saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone
25)formation. Can Med Assoc. J, 1979; 17: 658-665
26)Butz M: Oxalatsteinprophylaxe durch alkali-theriape. Urologe.
27)1982; 21: 142-146
28)Rudman D, Kutner MH, Redol SC, Waters WC, Gerron GG,
29)Bleier J: Hypocitraturia in calcium nephrolithiasis. J Clin
30)Endocrnol Metab. 1982; 55: 1052-1057
31)Nicar MJ, Skurla C, Sakhaec K, Pak CYC: Low urinary citrate
32)excretion in nephrolithiasis. Urology. 1983; 21: 8-14
33)Menon M., Mahle CJ: Urinary citrate excretion in patients renal
34)calculi. J Urol. 1983; 129: 1158-1160
35)Millan A, Conte A, Garcia Raso A, Grases F: Determination of
36)Citrate in urine by simple direct photometry. Clin Chem. 1987;
37)33: 1259-1260
38)Robertson WG, Peacock M, Nordin BEC: Activity products in
39)stone-forming and non stone-forming urine. Clin Sci. 1968; 32:
40)579-594
41)Robertson WG, Peacock M, Nordin BEC: Calcium oxalate
42)crystalluria and urine saturation in recurrent renal stone-formers.
43)Clin Sci. 1971; 40: 365-374
44)Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB:
45)Risk factors in calcium stone disease of the urinary tract. Br J
46)Urol.1978; 50: 449-454
47)Marshall RW, Barry HH: Urine Saturation and the formation of
48)calcium Containing Calculi. The effects of various forms of
49)therapy. Karger, Basel 1973
50)Fellstrom B, Backman U, Danielson BG, Johansson G, Ljunghall
51)S, Wikstrom B: Urinary excretion of urate in renal calcium stone
52)disease and tubular acidification disturbances. J Urol. 1982; 127:
53)589-592
54)Dumoulin G, Haton D, Wolf JP, Henriet MT, Nguyen NU,
55)Mougin C, Saint-Hiller Y, Combes M, Berthelay S: Comparative
56)study of urinary calcium, oxalate and uric acid in calcium oxalate
57)lithiasis. Nephrologie. 1984; 5: 189-191
58)Duranti E, Imperiali P, Badi M, Capiccioni S, Masi MG, Sasdelli
59)M: Study of inhibitor and nucleator activities in calcium stone
60)former. Proc Eur Dial Transplant Assoc. 1983; 20: 445-449
61)Conte A, Roca P, Gianotti M, Grases F: On the relation between
62)citrate and calcium in normal and stone-former subjects. Int Urol
63)Nephrol. 1990; 22: 7-12
64)Oehlschlager S, Albrecht S, Hakenberg OW, Schrodter S,
65)Froehner M, Manseck A, Wirth MP: Early changes of oxalate and
66)calcium urine excretion in those with calcium oxalate stone
67)formation after extracorporeal shock wave lithotripsy. Adult
68)Urology 2003;62: 17-21
69)Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H,
70)Akinci M: Metabolic Risk factors in pediatric and adult calcium
71)oxalate urinary stone formers: is there any difference? Urol Int.
72)2003; 70: 273-277
73)Ogawa Y, Yonou H, Hokama S, Oda M, Moruzumi M, Sugaya
74)K: Urinary saturation and risk factors for calcium oxalate stone
75)disease based on spot and 24-hour urine specimens. Front Biosci.
76)2003; 8: A167-A176
77)Scholz D, Schwille PO, Ulbrich D, Bausch WM, Sigel A:
78)Composition of renal stones and their frequency in a stone clinic:
79)relationship to parameters of mineral metabolism in serum and
80)urine. Urol Res. 1979; 7: 161-170.
© 2007 Fırat Tıp Dergisi. Tüm hakları saklıdır.

